153 related articles for article (PubMed ID: 26909416)
1. Self-assembling lipopeptides with a potent activity against Gram-positive bacteria, including multidrug resistant strains.
Azmi F; Elliott AG; Khalil ZG; Hussein WM; Kavanagh A; Huang JX; Quezada M; Blaskovich MA; Capon RJ; Cooper MA; Skwarczynski M; Toth I
Nanomedicine (Lond); 2015 Nov; 10(22):3359-71. PubMed ID: 26909416
[TBL] [Abstract][Full Text] [Related]
2. Short cationic lipopeptides as effective antibacterial agents: Design, physicochemical properties and biological evaluation.
Azmi F; Elliott AG; Marasini N; Ramu S; Ziora Z; Kavanagh AM; Blaskovich MA; Cooper MA; Skwarczynski M; Toth I
Bioorg Med Chem; 2016 May; 24(10):2235-41. PubMed ID: 27048775
[TBL] [Abstract][Full Text] [Related]
3. New Paenibacillus strain produces a family of linear and cyclic antimicrobial lipopeptides: cyclization is not essential for their antimicrobial activity.
Huang E; Yang X; Zhang L; Moon SH; Yousef AE
FEMS Microbiol Lett; 2017 Apr; 364(8):. PubMed ID: 28333237
[TBL] [Abstract][Full Text] [Related]
4. Ultra-short lipopeptides against gram-positive bacteria while alleviating antimicrobial resistance.
Zhong C; Zhang F; Zhu N; Zhu Y; Yao J; Gou S; Xie J; Ni J
Eur J Med Chem; 2021 Feb; 212():113138. PubMed ID: 33422980
[TBL] [Abstract][Full Text] [Related]
5. Potent Antimicrobial Activity of Lipidated Short α,γ-Hybrid Peptides.
Benke SN; Thulasiram HV; Gopi HN
ChemMedChem; 2017 Oct; 12(19):1610-1615. PubMed ID: 28834198
[TBL] [Abstract][Full Text] [Related]
6. Novel Cyclic Lipopeptide Antibiotics: Effects of Acyl Chain Length and Position.
Jensen SK; Thomsen TT; Oddo A; Franzyk H; Løbner-Olesen A; Hansen PR
Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32823798
[TBL] [Abstract][Full Text] [Related]
7. Biological and structural effects of the conjugation of an antimicrobial decapeptide with saturated, unsaturated, methoxylated and branched fatty acids.
Húmpola MV; Rey MC; Carballeira NM; Simonetta AC; Tonarelli GG
J Pept Sci; 2017 Jan; 23(1):45-55. PubMed ID: 28025839
[TBL] [Abstract][Full Text] [Related]
8. A novel tool against multiresistant bacterial pathogens: lipopeptide modification of the natural antimicrobial peptide ranalexin for enhanced antimicrobial activity and improved pharmacokinetics.
Domhan C; Uhl P; Meinhardt A; Zimmermann S; Kleist C; Lindner T; Leotta K; Mier W; Wink M
Int J Antimicrob Agents; 2018 Jul; 52(1):52-62. PubMed ID: 29649587
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo antibacterial evaluation and mechanistic study of ornithine based small cationic lipopeptides against antibiotic resistant clinical isolates.
Lohan S; Monga J; Cameotra SS; Bisht GS
Eur J Med Chem; 2014 Dec; 88():19-27. PubMed ID: 24961161
[TBL] [Abstract][Full Text] [Related]
10. Stalobacin: Discovery of Novel Lipopeptide Antibiotics with Potent Antibacterial Activity against Multidrug-Resistant Bacteria.
Matsui K; Kan Y; Kikuchi J; Matsushima K; Takemura M; Maki H; Kozono I; Ueda T; Minagawa K
J Med Chem; 2020 Jun; 63(11):6090-6095. PubMed ID: 32378891
[TBL] [Abstract][Full Text] [Related]
11. Effect of ester to amide or N-methylamide substitution on bacterial membrane depolarization and antibacterial activity of novel cyclic lipopeptides.
Bionda N; Fleeman RM; Shaw LN; Cudic P
ChemMedChem; 2013 Aug; 8(8):1394-402. PubMed ID: 23780744
[TBL] [Abstract][Full Text] [Related]
12. Systematic study of non-natural short cationic lipopeptides as novel broad-spectrum antimicrobial agents.
Lohan S; Cameotra SS; Bisht GS
Chem Biol Drug Des; 2013 Nov; 82(5):557-66. PubMed ID: 23819506
[TBL] [Abstract][Full Text] [Related]
13. Structure-activity relationships in ultrashort cationic lipopeptides: the effects of amino acid ring constraint on antibacterial activity.
Domalaon R; Yang X; O'Neil J; Zhanel GG; Mookherjee N; Schweizer F
Amino Acids; 2014 Nov; 46(11):2517-30. PubMed ID: 25069750
[TBL] [Abstract][Full Text] [Related]
14. In Vitro Activities of LCB 01-0648, a Novel Oxazolidinone, against Gram-Positive Bacteria.
Oh SH; Kim J; Baek SY; Chae SE; Park HS; Cho YL; Kwak JH
Molecules; 2017 Mar; 22(3):. PubMed ID: 28273820
[TBL] [Abstract][Full Text] [Related]
15. Key residues in octyl-tridecaptin A1 analogues linked to stable secondary structures in the membrane.
Cochrane SA; Findlay B; Vederas JC; Ratemi ES
Chembiochem; 2014 Jun; 15(9):1295-9. PubMed ID: 24816483
[TBL] [Abstract][Full Text] [Related]
16. Effect of Disulfide Cyclization of Ultrashort Cationic Lipopeptides on Antimicrobial Activity and Cytotoxicity.
Neubauer D; Jaśkiewicz M; Sikorska E; Bauer SBM; Kapusta M; Narajczyk M; Kamysz W
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 33003569
[TBL] [Abstract][Full Text] [Related]
17. Biofilm eradication kinetics of the ultrashort lipopeptide C12 -OOWW-NH2 utilizing a modified MBEC Assay(™).
Laverty G; Gorman SP; Gilmore BF
Chem Biol Drug Des; 2015 May; 85(5):645-52. PubMed ID: 25264285
[TBL] [Abstract][Full Text] [Related]
18. Trivalent ultrashort lipopeptides are potent pH dependent antifungal agents.
Arnusch CJ; Albada HB; van Vaardegem M; Liskamp RM; Sahl HG; Shadkchan Y; Osherov N; Shai Y
J Med Chem; 2012 Feb; 55(3):1296-302. PubMed ID: 22243686
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of peptoid mimics of short, lipophilic peptide antimicrobials.
Green RM; Bicker KL
Int J Antimicrob Agents; 2020 Aug; 56(2):106048. PubMed ID: 32540430
[TBL] [Abstract][Full Text] [Related]
20. Design and Solution-Phase Synthesis of Membrane-Targeting Lipopeptides with Selective Antibacterial Activity.
Konai MM; Adhikary U; Haldar J
Chemistry; 2017 Sep; 23(52):12853-12860. PubMed ID: 28718982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
